Decentralised germline genetic testing for epithelial ovarian cancer in a tertiary Asian centre
Authors:
Open Access
- 9 April 2026
- journal article
- Published by Academy of Medicine, Singapore in Annals of the Academy of Medicine, Singapore
- Vol. 55 (6) , 339
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Cost-Effectiveness Analysis of Germline and Somatic BRCA Testing in Patients With Advanced Ovarian CancerAnnals of Laboratory Medicine, 2022
- Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trialThe Lancet Oncology, 2021
- Mainstreaming genetic counselling for genetic testing of BRCA1/2 in ovarian cancer patients in Malaysia (MaGIC study)Annals of Oncology, 2019
- BRCA mutation in high grade epithelial ovarian cancersGynecologic Oncology Reports, 2019
- Inherited Mutations in Women With Ovarian CarcinomaJAMA Oncology, 2016
- Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocolAnnals of Oncology, 2016
- A cost analysis of a cancer genetic service model in the UKbioRxiv, 2015
- Referral of Ovarian Cancer Patients for Genetic Counselling by Oncologists: Need for ImprovementPublic Health Genomics, 2015
- Mainstreaming genetic testing of cancer predisposition genesClinical Medicine, 2014